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Introduction: For late-life neurocognitive disorders, as
for other late-life chronic diseases, much recent interest
has focused on the possible relevance of Developmental
Origins of Health and Disease (DOHaD). Programming
by undernutrition in utero, followed by overnutrition in
adult life may lead to an increased risk, possibly
mediated through cardiovascular and metabolic
pathways. This study will specifically examine, if lower
birth weight is associated with poorer cognitive
functioning in late life in a south Indian population.
Methods and analysis: From 1934 onwards, the
birth weight, length and head circumference of all
babies born in the CSI Holdsworth Memorial Hospital,
Mysore, India, were recorded in obstetric notes.
Approximately 800 men and women from the Mysore
Birth Records Cohort aged above 55 years, and a
reliable informant for each, will be asked to participate
in a single cross-sectional baseline assessment for
cognitive function, mental health and cardiometabolic
disorders. Participants will be assessed for
hypertension, type-2 diabetes and coronary heart
disease, nutritional status, health behaviours and
lifestyles, family living arrangements, economic status,
social support and social networks. Additional
investigations include blood tests (for diabetes, insulin
resistance, dyslipidaemia, anaemia, vitamin B12 and
folate deficiency, hyperhomocysteinemia, renal
impairment, thyroid disease and Apolipoprotein E
genotype), anthropometry, ECG, blood pressure,
spirometry and body composition (bioimpedance).
We will develop an analysis plan, first using traditional
univariate and multivariable analytical paradigms with
independent, dependent and mediating/confounding/
interacting variables to test the main hypotheses.
Ethics and dissemination: This study has been
approved by the research ethics committee of CSI
Holdsworth Memorial Hospital. The findings will be
disseminated locally and at international meetings, and
will be published in open access peer reviewed journals.
BACKGROUND
Neurocognitive disorders are a major cause
of disability and mortality in late life and are
associated with high costs for health systems
and society.1 It is estimated that in India, 3.7
million people aged over 60 have dementia
and this is expected to increase twofold by
2030 and threefold by 2050 because of steady
growth in the older population and stable
increments in life expectancy.2 In the
accompanying health transition, non-
communicable diseases have assumed a pro-
gressively greater signiﬁcance in low and
middle-income countries (LMICs) like India.
Although neurocognitive disorders are the
second highest source of burden after trop-
ical diseases, research in India is minimal.1 2
Recent research suggests that the quality of
nutrition during intrauterine development,
reﬂected crudely in size at birth, is an
important determinant of lifelong function,
Strengths and limitations of this study
▪ This study is the first lifecourse birth records
cohort study in the developing world with cogni-
tive, physical health and mental health outcomes
in older adults.
▪ This will add to the scientific understanding of
the early life origins of disease, and mediating
effect of cardiometabolic disorders in adult and
late life on late life cognitive abilities and mental
health in an Indian population.
▪ There have been large losses to follow-up since
birth, especially between birth and the first adult
follow-up, and the implications of these losses
have to be thought through in interpreting the
results of this study.
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health and disease risk.3 Birth weight and head circum-
ference at birth are indicators of intrauterine growth
and brain development, respectively.4 Larger birth
weight, the most widely researched birth size measure, is
associated with better cognitive function from infancy
through the third decade of life in several populations
and countries, independent of social background.5
However, this association between birth weight and cog-
nition diminishes as individuals reach middle age.6
Cohort studies with follow-up through late life have
been sparse, making the size of effects in late life
unclear.6 7 Head circumference at birth has shown a
similar pattern to birth weight, such that associations
observed in young cohorts were not replicated in the
older adults in follow-up studies.8 Conditions in early
postnatal life and childhood may supersede and com-
pensate for fetal vulnerabilities such as small birth size
and moderate long-term cognitive abilities.
Adult cardiometabolic disorders are also thought to
have origins in fetal life.8 Low birth weight is linked to
adult cardiometabolic disorders (type-2 diabetes, coron-
ary heart disease, hypertension and metabolic syn-
drome).9–12 These disorders are independently
associated with impaired cognition and dementia in old
age.13 While hypertension, obesity and hyperlipidaemia
in midlife predict an increased risk of later dementia,
associations become inverted in late life.14–16
Understanding long-term trajectories in Body Mass
Index (BMI), blood pressure and cholesterol among
those who do and do not develop cognitive impairment
can be clariﬁed by conducting prospective lifecourse
epidemiological studies.
Much interest has focused on the possible relevance of
Barker’s fetal and developmental origins of adult disease
(DOHaD) hypothesis with two plausible pathways to
late-onset cognitive impairment and dementia.17 18
1. a direct effect of reduced intrauterine nutrition
(reﬂected in smaller birth size) on fetal brain devel-
opment and leading to decreased cognitive abilities
and hence reduced cognitive reserve;17
2. programming of metabolism by undernutrition in
very early life, exacerbated by overnutrition in adult
life, leading to increased risk mediated through car-
diometabolic disease.13 17 18
Cognition in late life is impacted by the cumulative
effect of nutrition, education, social and family environ-
ment in early life and midlife.17 18 Adverse lifetime
socioeconomic conditions, including lower educational
attainment, less complex occupational activities, area of
birth and childhood residence are associated with cogni-
tive impairment and dementia.17 18 However, only a few
studies have examined the role of mediating factors
between socioeconomic deprivation across the life
course and cognitive ageing.17 19 Data spanning the life-
course into old age are hard to come by in LMICs. The
Mysore Birth Records Cohort20 in south India represents
a unique resource for the study of the lifecourse aeti-
ology of cognitive ageing in a radically different cultural
context from those where such studies have previously
been conducted.
Mysore Birth Records Cohort
CSI Holdsworth Memorial Hospital (HMH), Mysore,
India has preserved obstetric records since 1934 until
the present date. These include the birth weight, length
and head circumference of all babies born in the hos-
pital, as well as maternal weight and pelvic diameters.
During 1993–2001, in a collaborative study with Barker’s
group at the MRC Lifecourse Epidemiology Unit,
University of Southampton, UK, the records were used
to trace people born in HMH between 1934 and 1966.
The tracing process resulted in 3427 men and women
being matched to their birth records.20
Of those born between 1934 and 1966, 1069 partici-
pated in a study between 1993 and 1999 to evaluate the
relationship between size at birth and adult cardiometa-
bolic disorders.21–27 A subset (n=435) was assessed for
cardiac dimensions and arterial compliance 3–4 years
later.25 26 Ten years after the ﬁrst study, 383 participated
in a follow-up study for incident diabetes and metabolic
syndrome between 2003 and 2004.27
The 3427 cohort members who were retraced and
matched to their birth records in 1993–2001 were only a
small percentage (14%) of all the births in HMH during
1934–1966, and of these ∼30% (n=1069) took part in
the previous studies of the cohort. Compared with the
remainder of the original births, the 3427 individuals
who were traced were 48 g heavier (95% CI 28 to 68,
p<0.001), 0.25 cm longer (95% CI 0.08 to 0.42, p=0.005)
and had a 0.092 cm larger head circumference (95% CI
−0.004 to 0.188; p=0.06) at birth. Compared with the
3427, the 1069 men and women who were studied were
slightly lighter and shorter, but these differences were
not statistically signiﬁcant (birth weight −36 g (95% CI
−74 to 2, p=0.07); birth length −0.26 cm (95% CI −0.55
to 0.03, p=0.08).20
Previous studies from the Mysore Birth Records
Cohort provided partial support for the Barker hypoth-
esis, with predicted associations between lower birth
weight and coronary heart disease,21 insulin resistance22
and lower lung function.24 The prevalence and inci-
dence of type-2 diabetes was higher compared with the
west and was associated with short birth length rather
than low birth weight.21 27 Associations between cortisol
concentration and cardiovascular risk factors were stron-
ger.23 No associations were identiﬁed between birth
weight and hypertension, left ventricular mass and arter-
ial compliance.25 26
For the purpose of this study, we aim to investigate
∼800 men and women from the Mysore Birth Records
Cohort, born before 1959. There was no contact with
the cohort between 2005 and 2011. Between 2011 and
2015 we retraced the cohort members and of the 1069,
186 are deceased, 727 are alive and 156 could not be
traced. Recruitment for the study has started and the
study is expected to be completed by 2017.
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Aims and objectives
The full potential of this cohort will be realised through
repeated measures of cognitive and other functions in
older age, to track cognitive trajectories, and the
development of frailty across other physiological and
organ systems. The purpose of this study is to establish
baseline cognitive function in later life. We will be con-
ducting cognitive assessments for all participants once
during this study. However, to begin to explore pathways
from early life growth and development to late-life
impairment and decline, these assessments will be
repeated in future follow-up studies of the cohort.
Primary goal
This study aims to test the hypothesis that lower birth
weight and smaller head circumference at birth are asso-
ciated with poorer scores in tests of cognitive function in
people aged 55 years and over, relative to age and educa-
tion norms for the south Indian population. The medi-
ating effects of childhood growth (proxied by adult
head circumference and leg length), and cardiometa-
bolic risk factors (in adult and late life) will be explored.
Potential interactions will also be explored; for example,
the association between birth weight and late-life cogni-
tive ability may be modiﬁed by changes in socio-
economic status in midlife.
Other key goals
1. To estimate the prevalence of cognitive impairment
and its association with age, gender, education and
socioeconomic position. We will investigate risk
factors for cognitive impairment and test the follow-
ing speciﬁc hypotheses:
A. Cardiovascular risk factors (diabetes, hyperten-
sion, large waist circumference, high waist:hip
ratio, hypercholesterolaemia, hypertriglyceridae-
mia, metabolic syndrome, insulin resistance and
smoking), coronary heart disease and stroke are
associated with an increased risk of cognitive
impairment and dementias, after controlling for
confounding effects. Associations will be quanti-
ﬁed as relative risks and population attributable
fractions.
B. Micronutrient deﬁciencies (vitamin B12 and
folate), and anaemia are associated with an
increased risk of cognitive impairment.
C. ApoE4 (Apolipoprotein E4) genotype is asso-
ciated with an increased risk of cognitive impair-
ment and dementia.
D. Markers of socioeconomic adversity across life are
associated with an increased risk of cognitive
impairment and dementia.
2. We will study the social aetiology of late-life depres-
sion cross-sectionally including associations with rela-
tive and absolute poverty, ill health and disability,
nutritional status, social support, life events, marital
circumstances and living arrangements.
METHODS AND ANALYSIS
Study design
Approximately 800 men and women from the Mysore
Birth Records Cohort, and the original 3427 who were
traced and matched to their birth records, aged above
55 years, and a key informant will be asked to participate
in a cross-sectional comprehensive 1-phase baseline
assessment lasting ∼2–3 hours. Recruitment is expected
to complete by 2017 and our analyses by 2018.
Interviews and measures
A battery of cognitive tests and instruments developed,
validated and normed in India by the 10/66 Dementia
Research Group, suitable for people with little or no
education, is administered in local languages.28 29 30
Interviews for participants and key informant are carried
out in participants’ own homes. Physical assessments
and investigations are carried out the following day at
the research unit. There is good evidence to suggest that
adult head circumference and leg length are proxy
markers for early life growth and development. We are
measuring head circumference and leg length using
standardised protocols in the current study. Table 1 lists
the assessments and investigations that are conducted in
this study.
Blood tests and genetic assays: These are conducted
according to a standard protocol. Samples for biochem-
ical analyses are sent to the Diabetes Unit, KEM
Hospital, Pune, India, whose laboratory participates in
the UK National External Quality Assessment Service for
insulin assays. The DNA sample was sent to the Centre
for Cellular and Molecular Biology, Hyderabad, India,
where DNA is extracted for APOE genotyping.
The WHO criteria are employed to diagnose diabetes
and hypertension. Metabolic syndrome is diagnosed
using International Diabetes Federation criteria.31
Diagnosis of coronary heart disease is derived from an
algorithm, drawing information from the Rose Chest
Pain Questionnaire,32 Minnesota ECG coding33 and a
clinical history of cardiac revascularisation procedures.
Diagnosis of coronary heart disease is made, if there is
typical angina on Rose Chest Pain Questionnaire, or a
history of cardiac revascularisation procedures or the
presence of Minnesota codes 1–1 or 1–2 for major Q
waves on the ECG.
Outcomes: Cognitive functioning as a continuous
measure is obtained by administering the 10/66 battery
of cognitive tests.28–30 Cognitive impairment is deﬁned
as 1.5 SDs or more below the norm for the age and edu-
cational group for individual tests, and scoring below
that threshold on two out of three memory tests (imme-
diate and delayed recall and Community Screening
Instrument for Dementia (CSI‘D’) memory subscale).
Dementia is deﬁned by a score above a cut-off point of
predicted probability of Diagnostic Statistical Manual for
mental disorders (DSM) IV Dementia Syndrome34 from
the logistic regression equation of the 10/66 dementia
diagnostic algorithm.28 Depression is diagnosed from
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the computerised Geriatric Mental State Examination
algorithm (GMS-AGECAT).35
Power calculation and data analysis
Using a test at the 5% signiﬁcance level, our sample size
of 800 will provide 80% power to detect an association
of 0.099 SDs of a continuous outcome (cognitive score)
per SD of a continuous exposure (eg, birth weight). We
will ﬁrst calculate the prevalence of cognitive impair-
ment (outcome of interest) and its association with age
and gender.
Cardiometabolic data will be collected objectively
using standardised protocols in this study, and are avail-
able from previous two studies. We will use these data to
understand long-term trajectories in BMI, blood pres-
sure, and cholesterol among those with and without cog-
nitive impairment. Indicators of socioeconomic status
have been collected from the cohort members at the
time of birth (using data from maternity records), and
during adult life using standard methods when they
participated in previous studies. During this study, we
will conduct an assessment of current socioeconomic
position. We will examine for the association between
lifecourse socioeconomic position and cognitive func-
tion in late life in our analyses.
We will develop an analysis plan, ﬁrst using traditional
univariate and multivariable analytical paradigms with
independent, dependent and mediating/confounding/
interacting variables to test the main hypotheses. We will
then extend these analyses using path analysis and struc-
tural equation modelling by use of MPlus statistical soft-
ware package to explore lifecourse pathways and
mediated effects in more detail, allowing for the assumed
causal ordering of observed and latent variables (eg, cog-
nitive reserve) across the lifecourse.36 At the end of the
recruitment, we plan to compare participants in the
current study with non-participants. We will examine for
any differences in birth size, age, gender mix, height,
BMI, educational attainment, socioeconomic position
and cardiometabolic variables collected previously.
Table 1 Instruments, assessments and investigations in the study protocol
Battery of Cognitive tests 1. The Community Screening Instrument for Dementia (CSI‘D’) COGSCORE
incorporating the CERAD animal naming verbal fluency task. (CERAD—Consortium
to Establish a register for Alzheimer’s Disease)37
2. The modified CERAD 10-word list learning task with delayed recall38
3. Informant interview, the CSI‘D’ RELSCORE37, for evidence of cognitive and
functional decline*
Instruments for diagnosis of
dementia
1. Battery of cognitive tests (listed above)
2. A structured clinical mental state interview, the Geriatric Mental State, which applies
a computer algorithm35
3. An extended informant interview, the history and aetiology schedule—dementia
diagnosis and subtype39*
4. The NEUROEX, a brief fully structured neurological assessment40
5. Behavioural and psychological symptoms: assessed by Neuropsychiatric
Inventory41*
Health status and physical health
assessment
1. Self-reported global health by a structured interview†28
2. Self-reported diagnoses and treatments for these conditions†28
3. A self-reported list of 12 commonly occurring physical impairments†42
4. Activity limitation and participation restriction measured by the WHO—Disability
Assessment Schedule II†43
5. Rose Angina Questionnaire32
6. Direct physical assessments: pulse rate, systolic and diastolic resting blood pressure,
weight, height, leg length, head circumference, waist circumference, waist:hip ratio,
skin fold thickness (subscapular, triceps and abdominal), calf circumference, hand
grip test, bio impedance measurements, 12-lead ECG for Minnesota coding and 5 m
walking test
7. Reproductive status (for women)—menarche, menopause, reproductive period and
number of children
A structured interview† 1. Specific cognitive risk factors
2. Lifestyle and cardiovascular risk factors
Socioeconomic assessments 1. Modified Kuppuswamy Scale44†
2. Standard of Living Index45†
Blood tests and genetic assay Blood tests: Haemoglobin, glucose tolerance test, lipid profile, albumin, total protein,
thyroid function tests, vitamin B12, folate, insulin and creatinineGenetic assay: ApoE
lipoprotein
*Instruments administered to informants only.
†Instruments administered to the informants only if the participants have communication difficulties arising from cognitive problems, severe
mental illness, deafness or mutism.
ApoE, Apolipoprotein E.
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ETHICS AND DISSEMINATION
Full informed consent is obtained from the participants.
If the participant is illiterate, verbal consent is obtained,
witnessed and signed by a relative. If individuals were
unable to consent (due to severe cognitive problems),
witnessed assent is obtained from their nearest/
authorised relative. The ﬁndings from this study will be
disseminated locally and at international meetings, and
will be published in open access peer review journals.
DISCUSSION
India is experiencing a phenomenal increase in adult car-
diometabolic disorders, a trend attributed to wide spread
intrauterine and infant-growth retardation and recent
economic transition leading to unhealthy diets and life-
styles in childhood and adult life. These disorders in
adult life increase the risk of cognitive impairment in old
age where comorbidity with chronic non-communicable
disorders is common. Despite the growing interest in
chronic diseases in the elderly, there are few detailed
data available on their prevalence, impact and develop-
mental origins in the developing world.
This project constitutes a unique opportunity to begin
to chart the epidemiologic transition and its impact on
older persons in India. In addition to cognitive impair-
ment, this cross-sectional survey includes ascertainment
of mental disorders and other chronic conditions in late
life. As well as providing a rich baseline for studying the
aetiology of cognitive decline in future follow-up studies,
this will allow us to explore the relative, independent
and interactive contributions of various chronic condi-
tions to late-life cognitive functioning. We will carry out
comparative analyses using the publicly accessible data
archive from the 10/66 Dementia Research Group’s
cross-sectional population-based surveys including over
19 000 older people from 10 developing countries.
There have been large losses to follow-up since birth,
especially between birth and the ﬁrst adult follow-up,
and the implications of these losses have to be thought
through in interpreting the results of this study.
Numbers of older people are growing rapidly in India
and the extent to which nutrition in early life and cardio-
metabolic risk factors across the lifespan are related to
late-life cognition is of substantial public health relevance.
Understanding the nature of this relationship and identi-
ﬁcation of critical periods could strengthen the rationale
for policies to improve maternal and child nutrition and
to develop interventions to prevent or modify chronic
non-communicable disorders. Effective dissemination of
ﬁndings from this research will raise awareness, inform
evidence-based policymaking and enhance service devel-
opment for older people in India.
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